B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Blanco, Esther ^a   Cubillos, Carolina ^a   Moreno, Noelia ^a   Bárcena, Juan ^a   De La Torre, Beatriz G ^b   Andreu, David ^b   Sobrino, Francisco ^a,c  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; PEPTIDE; SUBUNIT VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; CLASSIFICATION; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMORAL IMMUNITY; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MICE; PEPTIDES; T-LYMPHOCYTES; VACCINES, SUBUNIT; VIRAL VACCINES;

EID: 84893777933     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/475960     Document Type: Article

References (37)

1. James A. D., Rushton J., The economics of foot and mouth disease. Revue Scientifique et Technique 2002 21 3 637 644 2-s2.0-0036944036 (Pubitemid 36080130)
2. Valarcher J.-F., Leforban Y., Rweyemamu M., Roeder P. L., Gerbier G., MacKay D. K. J., Sumption K. J., Paton D. J., Knowles N. J., Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. Transboundary and Emerging Diseases 2008 55 1 14 34 2-s2.0-38349135712 10.1111/j.1865-1682. 2007.01010.x
3. Sumption K., Rweyemamu M., Wint W., Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America; Combining expert opinion, official disease information and livestock populations to assist risk assessment. Transboundary and Emerging Diseases 2008 55 1 5 13 2-s2.0-38349093922 10.1111/j.1865-1682.2007.01017.x
4. Rodriguez L. L., Gay C. G., Development of vaccines toward the global control and eradication of foot-and-mouth disease. Expert Review of Vaccines 2011 10 3 377 387 2-s2.0-79953254318 10.1586/erv.11.4
5. Doel T. R., FMD vaccines. Virus Research 2003 91 1 81 99 2-s2.0-0037235390 10.1016/S0168-1702(02)00261-7 (Pubitemid 36078432)
6. Cottam E. M., Wadsworth J., Shaw A. E., Rowlands R. J., Goatley L., Maan S., Maan N. S., Mertens P. P. C., Ebert K., Li Y., Ryan E. D., Juleff N., Ferris N. P., Wilesmith J. W., Haydon D. T., King D. P., Paton D. J., Knowles N. J., Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007. PLoS Pathogens 2008 4 4 2-s2.0-43049110625 10.1371/journal.ppat.1000050 e1000050 (Pubitemid 351631074)
7. Kitching P., Hammond J., Jeggo M., Charleston B., Paton D., Rodriguez L., Heckert R., Global FMD control-Is it an option? Vaccine 2007 25 30 5660 5664 2-s2.0-34447255941 10.1016/j.vaccine.2006.10.052 (Pubitemid 47039262)
8. Sobrino F., Domingo E., Foot-and-mouth disease in Europe. FMD is economically the most important disease of farm animals. Its re-emergence in Europe is likely to have consequences that go beyond severe alterations of livestock production and trade. EMBO Reports 2001 2 6 459 461 2-s2.0-0034963149 (Pubitemid 32611338)
9. Purcell A. W., McCluskey J., Rossjohn J., More than one reason to rethink the use of peptides in vaccine design. Nature Reviews Drug Discovery 2007 6 5 404 414 2-s2.0-34247891741 10.1038/nrd2224 (Pubitemid 46696551)
10. Brun A., Bárcena J., Blanco E., Borrego B., Dory D., Escribano J. M., Le Gall-Reculé G., Ortego J., Dixon L. K., Current strategies for subunit and genetic viral veterinary vaccine development. Virus Research 2011 157 1 1 12 2-s2.0-79953029471 10.1016/j.virusres.2011.02.006
11. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F., The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 1989 337 6209 709 716 2-s2.0-0024578406 (Pubitemid 19064726)
12. Mateu M. G., Verdaguer N., Sobrino F., Domingo E., Functional and structural aspects of the interaction of foo-and-outh disease virus with antibodies. Foot-and-Mouth Disease: Current Perspectives 2004 Norfolk, UK Horizon Bioscience 223 260
13. Bittle J. L., Houghten R. A., Alexander H., Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982 298 5869 30 33 2-s2.0-0019959784 (Pubitemid 12087468)
14. Taboga O., Tami C., Carrillo E., Núñez J. I., Rodríguez A., Sáiz J. C., Blanco E., Valero M.-L., Roig X., Camarero J. A., Andreu D., Mateu M. G., Giralt E., Domingo E., Sobrino F., Palma E. L., A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. Journal of Virology 1997 71 4 2606 2614 2-s2.0-0030999059 (Pubitemid 27119896)
15. McCullough K. C., De Simone F., Brocchi E., Capucci L., Crowther J. R., Kihm U., Protective immune response against foot-and-mouth disease. Journal of Virology 1992 66 4 1835 1840 2-s2.0-0026561506
16. Blanco E., Garcia-Briones M., Sanz-Parra A., Gomes P., De Oliveira E., Luz Valero M., Andreu D., Ley V., Sobrino F., Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. Journal of Virology 2001 75 7 3164 3174 2-s2.0-0035109177 10.1128/JVI.75.7.3164-3174.2001 (Pubitemid 32225880)
17. Cubillos C., Garcia de la Torre B., Barcena J., Andreu D., Sobrino F., Blanco E., Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site. Virology Journal 2012 66 2-s2.0-84858020968 10.1186/1743-422X-9-66
18. Cubillos C., de la Torre B. G., Jakab A., Clementi G., Borrás E., Bárcena J., Andreu D., Sobrino F., Blanco E., Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. Journal of Virology 2008 82 14 7223 7230 2-s2.0-47049094820 10.1128/JVI.00401-08 (Pubitemid 351977739)
19. Sumption K., Pinto P., Lubroth J., Foot-and-Mouth disease situation worldwide and major epidemiological events in 2005-2006. FAO EMPRES Focus on 2007, http://www.fao.org/docs/eims/upload//225050/Focus-ON-1-07-en.pdf
20. Monso M., de la Torre B. G., Blanco E., Moreno N., Andreu D., Influence of conjugation chemistry and B epitope orientation on the immune response of branched peptide antigens. Bioconjugate Chemistry 2013 24 4 578 585
21. Borras-Cuesta F., Fedon Y., Petit-Camurdan A., Enhancement of peptide immunogenicity by linear polymerization. European Journal of Immunology 1988 18 2 199 202 2-s2.0-0023839711 (Pubitemid 18078843)
22. Golding S. M., Hedger R. S., Talbot P., Watson J., Radial immuno diffusion and serum neutralisation techniques for the assay of antibodies to swine vesicular disease. Research in Veterinary Science 1976 20 2 142 147 2-s2.0-0017263760
23. Leclerc C., New approaches in vaccine development. Comparative Immunology, Microbiology & Infectious Diseases 2003 26 329 341 (Pubitemid 37168471)
24. Rowlands D., Sobrino F., Domingo E., Foot-and-mouth disease virus peptide vaccines. Foot-and- Mouth Disease: Current Perspectives 2004 Norfolk, UK Horizon Bioscience 335 354
25. Bachmann M. F., Rohrer U. H., Kundig T. M., Burki K., Hengartner H., Zinkernagel R. M., The influence of antigen organization on B cell responsiveness. Science 1993 262 5138 1448 1451 2-s2.0-0027764291 (Pubitemid 24035067)
26. Zinkernagel R. M., On natural and artificial vaccinations. Annual Review of Immunology 2003 21 515 546 2-s2.0-0041468871 10.1146/annurev.immunol.21. 120601.141045 (Pubitemid 37174540)
27. Gamvrellis A., Leong D., Hanley J. C., Xiang S. D., Mottram P., Plebanski M., Vaccines that facilitate antigen entry into dendritic cells. Immunology and Cell Biology 2004 82 5 506 516 2-s2.0-7044251994 10.1111/j.0818-9641.2004. 01271.x (Pubitemid 39421060)
28. Carrillo C., Tulman E. R., Delhon G., Lu Z., Carreno A., Vagnozzi A., Kutish G. F., Rock D. L., Comparative genomics of foot-and-mouth disease virus. Journal of Virology 2005 79 10 6487 6504 2-s2.0-18144374835 10.1128/JVI.79.10. 6487-6504.2005 (Pubitemid 40617252)
29. Juleff N., Windsor M., Lefevre E. A., Gubbins S., Hamblin P., Reid E., McLaughlin K., Beverley P. C. L., Morrison I. W., Charleston B., Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle. Journal of Virology 2009 83 8 3626 3636 2-s2.0-64049094330 10.1128/JVI.02613-08
30. McCullough K. C., Sobrino F., Sobrino F., Domingo E., Immunology of foot-and-mouth disease. Foot-and-Mouth Disease: Current Perspectives 2004 Norfolk, UK Horizon Bioscience 173 222
31. Francis M. J., Black L., Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination. Journal of Hygiene 1983 91 2 329 334 2-s2.0-0021020672 (Pubitemid 14206541)
32. Fischer D., Rood D., Barrette R. W., Zuwallack A., Kramer E., Brown F., Silbart L. K., Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge. Journal of Virology 2003 77 13 7486 7491 2-s2.0-0038805626 10.1128/JVI.77.13.7486-7491.2003 (Pubitemid 36734518)
33. Eblé P. L., Bouma A., Weerdmeester K., Stegeman J. A., Dekker A., Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Vaccine 2007 25 6 1043 1054 2-s2.0-33845576105 10.1016/j.vaccine.2006.09.066 (Pubitemid 44937453)
34. Holmgren J., Czerkinsky C., Mucosal immunity and vaccines. Nature Medicine 2005 11 4 S45 S53 2-s2.0-17644371966 10.1038/nm1213 (Pubitemid 40562303)
35. Brandtzaeg P., Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007 25 30 5467 5484 2-s2.0-34447099136 10.1016/j.vaccine. 2006.12.001 (Pubitemid 47031365)
36. Bouvet J.-P., Decroix N., Pamonsinlapatham P., Stimulation of local antibody production: parenteral or mucosal vaccination? Trends in Immunology 2002 23 4 209 213 2-s2.0-0036533644 10.1016/S1471-4906(02)02186-5 (Pubitemid 34260937)
37. Silva-Flannery L. M., Cabrera-Mora M., Dickherber M., Moreno A., Polymeric linear peptide chimeric vaccine-induced antimalaria immunity is associated with enhanced in vitro antigen loading. Infection and Immunity 2009 77 5 1798 1806 2-s2.0-65449181181 10.1128/IAI.00470-08